Targeting Myeloid CD36 to Enhance Macrophage-Mediated Immunity: A Novel Strategy Against Hepatic Fibrosis

Highlight

  • Macrophage CD36 mediates uptake of hepatic stellate cell-derived lipids, triggering lipid peroxidation and ferroptosis, impairing adaptive immunity.
  • Myeloid-specific CD36 deficiency enhances macrophage antigen presentation via cGAS-STING pathway activation and promotes CD8+ T cell activation in liver fibrosis.
  • Single-cell RNA sequencing reveals upregulation of MHC-I genes in CD36-deficient macrophages within fibrotic liver microenvironment.
  • Clinical correlations demonstrate elevated CD36 expression in cirrhotic patients, supporting translational relevance of targeting CD36 in hepatic fibrosis.

Study Background and Disease Burden

Specialty calculators

Browse calculators

For clinical reference; use professional judgment.

Comments

No comments yet. Why don’t you start the discussion?

Leave a Reply